225Ac/89Zr-Labeled N4MU01 Radioimmunoconjugates as Theranostics Against Nectin-4–Positive Triple-Negative Breast Cancer

© 2025 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: https://jnm.snmjournals.org/page/permissions.

Author Information

Hanan Babeker¹,²,
Fabrice Ngoh Njotu¹,²,³,⁴,
Jessica Pougoue Ketchemen¹,³,⁴,
Alissar Monzer¹,
Anjong Florence Tikum¹,
Alireza Doroudi¹,
Emmanuel Nwangele¹,²,³,⁴,
Maruti Uppalapati² and
Humphrey Fonge¹,³,⁴

¹Department of Medical Imaging, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada;
²Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada;
³Axe Oncologie, Centre de Recherche du CHU de Québec-Université Laval, Québec, Quebec, Canada; and
⁴Faculté de Pharmacie, Université Laval, Ferdinand Andry Pavillon, Québec City, Quebec, Canada

For correspondence or reprints, contact Humphrey Fonge (humphrey.fonge{at}crchudequebec.ulaval.ca) or Maruti Uppalapati (maruti.uppalapati{at}usask.ca).

View Full Text